ARCHIVES

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 4 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984